LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

PerkinElmer Inc

Suletud

SektorTervishoid

0

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad

By Trading Economics

Sissetulek

-52M

42M

Müük

-65M

665M

P/E

Sektori keskmine

40.465

56.602

Aktsiakasum

1.01

Dividenditootlus

0.28

Kasumimarginaal

6.354

Töötajad

11,000

EBITDA

-151M

72M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+26.61% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.28%

2.45%

Järgmine tulemuste avaldamine

28. juuli 2025

Järgmine dividendimakse kuupäev

8. aug 2025

Järgmine aktsia dividendi kuupäev (ex-date)

18. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-2.5B

12B

Eelmine avamishind

0

Eelmine sulgemishind

0

Uudiste sentiment

By Acuity

34%

66%

86 / 382 Pingereas Healthcare

PerkinElmer Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. mai 2025, 23:47 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over U.S. Tariffs -- Market Talk

18. mai 2025, 23:40 UTC

Market Talk

Gold Rises Amid Concerns Over U.S. Fiscal Deficit -- Market Talk

18. mai 2025, 18:00 UTC

Tulu

Tax Bill News; Target, Home Depot, and Snowflake Earnings; and More Stock Market News to Watch This Week -- Barrons.com

18. mai 2025, 17:01 UTC

Peamised uudised

GM Is Fighting California on EVs. This Is What It Wants to Overturn and Why. -- Barrons.com

18. mai 2025, 16:20 UTC

Tulu

Tesla Demand Hasn't Rebounded Yet. Watch China This Week. -- Barrons.com

18. mai 2025, 12:09 UTC

Peamised uudised

Trump Sounds Upbeat on Ukraine Cease-Fire as Russia Unleashes Drone Barrage -- WSJ

17. mai 2025, 17:15 UTC

Peamised uudised

Trump Attacks Walmart for Tariff-Related Price Increases -- WSJ

17. mai 2025, 09:30 UTC

Peamised uudised
Tulu

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17. mai 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. mai 2025, 08:20 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

16. mai 2025, 23:18 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16. mai 2025, 22:30 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- Update

16. mai 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16. mai 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. mai 2025, 21:54 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- WSJ

16. mai 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16. mai 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16. mai 2025, 21:17 UTC

Peamised uudised

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16. mai 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16. mai 2025, 20:55 UTC

Omandamised, ülevõtmised, äriostud

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. mai 2025, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

16. mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. mai 2025, 20:37 UTC

Peamised uudised

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16. mai 2025, 20:33 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16. mai 2025, 20:30 UTC

Omandamised, ülevõtmised, äriostud

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16. mai 2025, 20:18 UTC

Peamised uudised

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16. mai 2025, 20:16 UTC

Peamised uudised

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16. mai 2025, 20:15 UTC

Tulu

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16. mai 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein: William K. Daniel Joins Board

16. mai 2025, 20:10 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein: Strategic Investment by KKR Completed

Võrdlus sarnastega

Hinnamuutus

PerkinElmer Inc Prognoos

Hinnasiht

By TipRanks

26.61% tõus

12 kuu keskmine prognoos

Keskmine 118.08 USD  26.61%

Kõrge 135 USD

Madal 100 USD

Põhineb 14 Wall Streeti analüütiku instrumendi PerkinElmer Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

9

Osta

5

Hoia

0

Müü

Sentiment

By Acuity

86 / 382 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.